X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3329) 3329
Publication (163) 163
Book Review (41) 41
Magazine Article (31) 31
Book Chapter (21) 21
Book / eBook (12) 12
Dissertation (3) 3
Newsletter (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Journal / eJournal (1) 1
Paper (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2933) 2933
antifibrinolytic agents - therapeutic use (1952) 1952
female (1354) 1354
male (1166) 1166
index medicus (1132) 1132
middle aged (765) 765
adult (748) 748
tranexamic acid - therapeutic use (747) 747
tranexamic acid (669) 669
aged (607) 607
antifibrinolytic agents - administration & dosage (575) 575
antifibrinolytic agents (503) 503
surgery (477) 477
treatment outcome (464) 464
fibrinolysis (354) 354
tranexamic acid - administration & dosage (346) 346
blood transfusion (329) 329
antifibrinolytic agents - adverse effects (324) 324
hematology (324) 324
animals (294) 294
blood loss, surgical - prevention & control (288) 288
adolescent (266) 266
medicine, general & internal (264) 264
hemorrhage - drug therapy (258) 258
antifibrinolytic agents - pharmacology (239) 239
hemorrhage (234) 234
prospective studies (222) 222
management (213) 213
retrospective studies (211) 211
abridged index medicus (210) 210
child (209) 209
risk factors (204) 204
anesthesiology (198) 198
peripheral vascular disease (192) 192
pregnancy (192) 192
transfusion (190) 190
mortality (185) 185
anticoagulants - therapeutic use (182) 182
tranexamic acid - adverse effects (180) 180
therapy (177) 177
aged, 80 and over (172) 172
aprotinin (171) 171
cardiopulmonary bypass (170) 170
time factors (169) 169
hemorrhage - etiology (160) 160
fibrinolysis - drug effects (159) 159
hemostasis (155) 155
drug therapy (154) 154
aminocaproic acid - therapeutic use (151) 151
plasma (150) 150
hemostatics - therapeutic use (146) 146
vitamin k - therapeutic use (145) 145
cardiac-surgery (144) 144
clinical neurology (143) 143
aprotinin - therapeutic use (139) 139
coagulation (139) 139
antifibrinolytics (138) 138
administration, oral (136) 136
double-blind method (136) 136
health aspects (136) 136
postoperative hemorrhage - prevention & control (136) 136
randomized controlled trials as topic (136) 136
cardiac & cardiovascular systems (135) 135
care and treatment (134) 134
blood-loss (132) 132
young adult (131) 131
anticoagulants - adverse effects (129) 129
double-blind (127) 127
bleeding (126) 126
blood coagulation disorders - drug therapy (123) 123
orthopedics (123) 123
analysis (119) 119
antifibrinolytic therapy (119) 119
risk (118) 118
blood coagulation tests (116) 116
hemorrhage - prevention & control (116) 116
infant (116) 116
pharmacology & pharmacy (114) 114
blood coagulation - drug effects (113) 113
thrombosis (113) 113
menorrhagia - drug therapy (112) 112
epsilon-aminocaproic acid (111) 111
research (111) 111
anticoagulants (110) 110
drug therapy, combination (110) 110
heparin - therapeutic use (110) 110
recombinant proteins - therapeutic use (109) 109
recurrence (108) 108
subarachnoid hemorrhage - drug therapy (107) 107
child, preschool (104) 104
metaanalysis (104) 104
diagnosis (102) 102
dosage and administration (102) 102
efficacy (101) 101
warfarin (101) 101
trauma (100) 100
hemorrhage - therapy (99) 99
international normalized ratio (98) 98
acids (97) 97
aminocaproates - therapeutic use (97) 97
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2722) 2722
German (240) 240
French (98) 98
Japanese (71) 71
Italian (61) 61
Russian (48) 48
Spanish (41) 41
Polish (20) 20
Czech (18) 18
Dutch (14) 14
Danish (13) 13
Swedish (13) 13
Chinese (9) 9
Portuguese (8) 8
Bulgarian (7) 7
Norwegian (3) 3
Romanian (3) 3
Ukrainian (3) 3
Croatian (2) 2
Finnish (2) 2
Hungarian (2) 2
Hebrew (1) 1
Korean (1) 1
Persian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Heart Journal, ISSN 0195-668X, 2012, Volume 33, Issue 20, pp. 2569 - 2619
Acute coronary syndromes Ischaemic heart disease | Reperfusion therapy | Primary percutaneous coronary intervention Antithrombotic therapy | Secondary prevention | Acute myocardial infarction | ST-segment elevation | Guidelines | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL STENTS | Primary percutaneous coronary intervention | AMERICAN-HEART-ASSOCIATION | PERCUTANEOUS CORONARY INTERVENTION | INTRAAORTIC BALLOON COUNTERPULSATION | Antithrombotic therapy | LEFT-VENTRICULAR DYSFUNCTION | DUAL ANTIPLATELET THERAPY | SUSPECTED CARDIOGENIC-SHOCK | IN-HOSPITAL MORTALITY | Acute coronary syndromes | Ischaemic heart disease | CONVERTING-ENZYME INHIBITOR | DRUG-ELUTING STENTS | Antifibrinolytic Agents - therapeutic use | Humans | Heart Failure - physiopathology | Hyperglycemia - complications | Anxiety - prevention & control | Long-Term Care | Hemodynamics - physiology | Cardiomyopathies - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Myocardial Infarction - therapy | Out-of-Hospital Cardiac Arrest - therapy | Percutaneous Coronary Intervention - methods | Fibrinolytic Agents - therapeutic use | Electrocardiography | Cardiac Imaging Techniques - methods | Platelet Aggregation Inhibitors - therapeutic use | Dyspnea - prevention & control | Exercise Therapy - methods | Myocardial Infarction - diagnosis | Heart Failure - complications | Coronary Artery Bypass - methods | Arrhythmias, Cardiac - therapy | Pain - prevention & control | Risk Assessment | Risk Reduction Behavior | Time-to-Treatment | Emergency Treatment - methods | Biomedical Research - trends | Arrhythmias, Cardiac - etiology | Hospitalization | Out-of-Hospital Cardiac Arrest - diagnosis | Forecasting | Myocardial Reperfusion - methods | Cardiomyopathies - therapy | Myocardial Infarction - complications | Emergency Medical Services - organization & administration | General Practice - organization & administration | Hyperglycemia - therapy
Journal Article
Medical hemostasis in experimental liver resection with antifibrinolytic therapy, 07/2004
AIMS: To study the efficacy of aprotinin in controlling bleeding from parenchymatous organ trauma. MATERIALS AND METHODS: Thirty-two guinea pigs were utilized... 
Medical hemostasis, blood conservation, antifibrinolytic therapy is04053 | Surgery
Journal
12/2016, Frontiers of Neurology and Neuroscience, ISBN 3318027588, Volume 40, 11
Symptomatic cerebral atherosclerosis including intracranial atherosclerosis (ICAS) is associated with a high risk of recurrent stroke. Antithrombotic agents... 
Chapter | Intracranial Arteriosclerosis - drug therapy | Antifibrinolytic Agents - therapeutic use | Fibrinolytic Agents - therapeutic use | Humans
Book Chapter
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2013, Volume 368, Issue 2, pp. 128 - 137
Journal Article